questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de transport
Protéines AAA
ATPases associated with diverse cellular activities
ATP-dependent proteases
ATP-dependent proteases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent proteases : Questions médicales les plus fréquentes",
"headline": "ATP-dependent proteases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ATP-dependent proteases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-23",
"dateModified": "2025-02-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ATP-dependent proteases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "ATPases associated with diverse cellular activities",
"url": "https://questionsmedicales.fr/mesh/D000074183",
"about": {
"@type": "MedicalCondition",
"name": "ATPases associated with diverse cellular activities",
"code": {
"@type": "MedicalCode",
"code": "D000074183",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "ATP-dependent endopeptidases",
"alternateName": "ATP-Dependent Endopeptidases",
"url": "https://questionsmedicales.fr/mesh/D057065",
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent endopeptidases",
"code": {
"@type": "MedicalCode",
"code": "D057065",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protease La",
"alternateName": "Protease La",
"url": "https://questionsmedicales.fr/mesh/D049070",
"about": {
"@type": "MedicalCondition",
"name": "Protease La",
"code": {
"@type": "MedicalCode",
"code": "D049070",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.157.025.750.032.099.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "ATP-dependent proteases",
"alternateName": "ATP-Dependent Proteases",
"code": {
"@type": "MedicalCode",
"code": "D049069",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Zhou Sha",
"url": "https://questionsmedicales.fr/author/Zhou%20Sha",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA."
}
},
{
"@type": "Person",
"name": "Jennifer Fishovitz",
"url": "https://questionsmedicales.fr/author/Jennifer%20Fishovitz",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry and Physics, Saint Mary's College, Notre Dame, Indiana, 46556, USA."
}
},
{
"@type": "Person",
"name": "Sujatha Chilakala",
"url": "https://questionsmedicales.fr/author/Sujatha%20Chilakala",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA."
}
},
{
"@type": "Person",
"name": "Yan Xu",
"url": "https://questionsmedicales.fr/author/Yan%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Cleveland State University, Cleveland, Ohio, 44115, USA."
}
},
{
"@type": "Person",
"name": "Irene Lee",
"url": "https://questionsmedicales.fr/author/Irene%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Case Western Reserve University, Cleveland, Ohio, 44106, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Gadolinium-Bisphosphonate Nanoparticle-Based Low-Dose Radioimmunotherapy for Osteosarcoma.",
"datePublished": "2022-11-16",
"url": "https://questionsmedicales.fr/article/36383732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsbiomaterials.2c00880"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gadolinium Deposition Disease: Current State of Knowledge and Expert Opinion.",
"datePublished": "2023-04-11",
"url": "https://questionsmedicales.fr/article/37058336",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLI.0000000000000977"
}
},
{
"@type": "ScholarlyArticle",
"name": "European fluxes of medical gadolinium to the ocean: A model based on healthcare databases.",
"datePublished": "2023-03-06",
"url": "https://questionsmedicales.fr/article/36913780",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.envint.2023.107868"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diffusion-weighted and gadolinium-enhanced dynamic MRI in parotid gland tumors.",
"datePublished": "2022-08-11",
"url": "https://questionsmedicales.fr/article/35951107",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00405-022-07590-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Gadolinium Enhances Dual-energy Computed Tomography Scan of Pulmonary Artery.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36190598",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11596-022-2621-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de transport",
"item": "https://questionsmedicales.fr/mesh/D002352"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines AAA",
"item": "https://questionsmedicales.fr/mesh/D000074582"
},
{
"@type": "ListItem",
"position": 6,
"name": "ATPases associated with diverse cellular activities",
"item": "https://questionsmedicales.fr/mesh/D000074183"
},
{
"@type": "ListItem",
"position": 7,
"name": "ATP-dependent proteases",
"item": "https://questionsmedicales.fr/mesh/D049069"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ATP-dependent proteases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ATP-dependent proteases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ATP-dependent proteases",
"description": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?\nQuels tests sanguins sont utiles pour évaluer ces protéases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec ces enzymes ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ATP-dependent proteases",
"description": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?\nLes troubles neurologiques sont-ils liés à ces protéases ?\nComment la dégradation des protéines affecte-t-elle la santé ?\nY a-t-il des signes cutanés associés à ces troubles ?\nLes douleurs musculaires peuvent-elles être un symptôme ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ATP-dependent proteases",
"description": "Comment prévenir les troubles liés aux protéases ?\nL'exercice physique joue-t-il un rôle préventif ?\nLes contrôles médicaux réguliers sont-ils importants ?\nY a-t-il des vaccins pour prévenir ces troubles ?\nLe stress peut-il affecter la fonction des protéases ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ATP-dependent proteases",
"description": "Quels traitements existent pour les troubles liés aux protéases ?\nLes suppléments alimentaires peuvent-ils aider ?\nLa thérapie génique est-elle une option ?\nLes médicaments anti-inflammatoires sont-ils utiles ?\nComment la physiothérapie peut-elle aider ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ATP-dependent proteases",
"description": "Quelles complications peuvent survenir avec des troubles protéolytiques ?\nLes complications cardiovasculaires sont-elles possibles ?\nComment les troubles protéolytiques affectent-ils le système immunitaire ?\nY a-t-il un risque accru de cancer ?\nLes troubles neurologiques peuvent-ils s'aggraver ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ATP-dependent proteases",
"description": "Quels sont les facteurs de risque pour les troubles protéolytiques ?\nLe mode de vie influence-t-il ces risques ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?",
"url": "https://questionsmedicales.fr/mesh/D049069?mesh_terms=Gadolinium&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéases ATP-dépendantes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses protéomiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour évaluer ces protéases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages d'enzymes spécifiques et des marqueurs de dégradation protéique sont recommandés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies peuvent aider à évaluer l'activité des protéases dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec ces enzymes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, la perte de poids et des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux protéases ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à visualiser des anomalies tissulaires, mais pas directement les protéases."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en protéases ATP-dépendantes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, troubles digestifs, et accumulation de protéines mal repliées peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés à ces protéases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements peuvent entraîner des troubles neurologiques et cognitifs."
}
},
{
"@type": "Question",
"name": "Comment la dégradation des protéines affecte-t-elle la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une dégradation inappropriée peut mener à des maladies dégénératives et à l'inflammation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés à ces troubles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des problèmes de cicatrisation peuvent être observés."
}
},
{
"@type": "Question",
"name": "Les douleurs musculaires peuvent-elles être un symptôme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires peuvent survenir en raison d'une dégradation protéique anormale."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux protéases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir leur fonction."
}
},
{
"@type": "Question",
"name": "L'exercice physique joue-t-il un rôle préventif ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé musculaire et enzymatique."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies protéolytiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ces troubles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour ces troubles enzymatiques."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter la fonction des protéases ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber l'équilibre enzymatique et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les troubles liés aux protéases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies enzymatiques et des médicaments ciblant les voies protéolytiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les suppléments alimentaires peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains suppléments peuvent soutenir la fonction protéolytique et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est explorée pour corriger des déficiences enzymatiques spécifiques."
}
},
{
"@type": "Question",
"name": "Les médicaments anti-inflammatoires sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent réduire l'inflammation causée par une dégradation protéique anormale."
}
},
{
"@type": "Question",
"name": "Comment la physiothérapie peut-elle aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie peut améliorer la fonction musculaire et réduire la douleur associée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles protéolytiques ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maladies dégénératives, des troubles métaboliques et des infections peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres protéolytiques peuvent contribuer à des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les troubles protéolytiques affectent-ils le système immunitaire ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent affaiblir le système immunitaire, rendant l'organisme plus vulnérable aux infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la dégradation des protéines peuvent être liées à certains cancers."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils s'aggraver ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles protéolytiques non traités peuvent aggraver les symptômes neurologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles protéolytiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, des antécédents familiaux et des maladies métaboliques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il ces risques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent les risques."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent perturber la fonction des protéases et entraîner des complications."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la régulation des protéases et la santé globale."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines peut-elle augmenter le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines toxines peuvent altérer la fonction des protéases et causer des dommages cellulaires."
}
}
]
}
]
}
Osteosarcoma is a malignant osteogenic tumor with a high metastatic rate commonly occurring in adolescents. Although radiotherapy is applied to treat unresectable osteosarcoma with radiation resistanc...
This review describes the current knowledge of a form of gadolinium toxicity termed gadolinium deposition disease (GDD), supplemented with the opinions of the authors developed during 6 years of clini...
Marine ecosystems are exposed to a multitude of stresses, including emerging metals as Rare Earth Elements. The management of these emerging contaminants represents a significant environmental issue. ...
To evaluate the value of diffusion-weighted imaging and dynamic contrast-enhanced MRI for the diagnosis of parotid gland tumors....
Retrospective review of patients with surgically treated parotid tumors between January 2009 and June 2020, who underwent a preoperative parotid gland MRI including standard morphological sequences, d...
Inclusion of 133 patients (mean age: 53 years). Multiparametric MRI had a sensitivity of 90.3%, a specificity of 77.5%, an overall accuracy of 80.5%, a positive predictive value of 54.9% and a negativ...
Combining diffusion-weighted and gadolinium-enhanced dynamic sequences, in addition to morphological ones enables high (> 90%) sensitivity to detect malignant parotid gland tumors. It also gives the p...
To evaluate the feasibility of using gadopentetate dimeglumine (Gd-DTPA) for dual-energy computed tomography pulmonary angiography (CTPA)....
Sixty-six patients were randomly divided into three groups and underwent CTPA. Group A had a turbo flash scan using an iohexol injection, Group B had a turbo flash scan using Gd-DTPA, and Group C had ...
The pulmonary artery CT values were significantly higher in Group C...
Gd-CTPA is recommended to patients who are unsuitable for receiving an iodine-based CTPA. Furthermore, a turbo flash scan could surpass a dual-energy scan without consideration for virtual monoenerget...
With the development of inner ear gadolinium imaging technology, its clinical application is more and more frequent....
To explore the application value of inner ear MRI after intravenous gadolinium injection in sudden sensorineural hearing loss....
The clinical data of 28 patients who were preliminarily diagnosed with sudden sensorineural hearing loss and the results of intravenous gadolinium MRI examination were analyzed to find the relationshi...
Of the 28 patients (30 ears) with idiopathic sudden sensorineural hearing loss, 20 (71.4%) showed normal MRI. MRI abnormalities related to hearing loss were found in 8 cases (28.6%), of which 5 cases ...
Inner ear MRI after intravenous gadolinium injection can be used as an index to detect the cause of sudden deafness, one of the factors to guide clinical treatment, and an important means to further e...
Dilated cardiomyopathy (DCM) is an inevitable complication of Duchenne muscular dystrophy (DMD). Late gadolinium enhancement (LGE) demonstrated by cardiac MRI occurs in DMD-related DCM, indicating myo...
Anteroseptal location of late gadolinium enhancement (LGE) in patients with acute myocarditis (AM) detected by cardiovascular magnetic resonance may indicate an independent marker of unfavorable outco...
Gadolinium chelates for tumor magnetic resonance imaging (MRI) face challenges such as inadequate sensitivity, lack of selectivity, and risk of Gd leakage. This study presents a single-atom Gd nano-co...
In order to achieve smart biomedical micro/nanomaterials, promote interaction with biomolecules, improve osteogenic/chondrogenic differentiation, exhibit better dispersion in bone implants and ultimat...